Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

by Sung Gwe Ahn, Yoon Jin Cha, Soon June Bae, Chanik Yoon, Hak Woo Lee, Joon Jeong
Published 2018-03-01

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.

by Sung Gwe Ahn, Soong June Bae, Changik Yoon, Yoon Jin Cha, Hak Woo Lee, Seung Ah Lee, Joon Jeong
Published 2017-01-01

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

by Sung Gwe Ahn, Hak Min Lee, Hak Woo Lee, Seung Ah Lee, Se-Ra Lee, Sun-Hee Leem, Joon Jeong, In-Sun Chu
Published 2013-12-01

Comparison of patients with small (≤2 cm) breast cancer according to adherence to breast screening program.

by Jung Min Park, Soong Jun Bae, Changik Yoon, Hye Sun Lee, Hak Woo Lee, Sung Gwe Ahn, Seung Ah Lee, Joon Jeong
Published 2017-01-01

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.

by Sung Gwe Ahn, Jae-Hoon Lee, Hak Woo Lee, Tae Joo Jeon, Young Hoon Ryu, Kun Min Kim, Joohyuk Sohn, Mijin Yun, Seung Ah Lee, Joon Jeong, Seung Il Kim
Published 2017-01-01